New evidence from hyperspectral imaging analysis on the effect of photobiomodulation therapy on normal skin oxygenation

Lasers Med Sci. 2022 Apr;37(3):1539-1547. doi: 10.1007/s10103-021-03397-9. Epub 2021 Aug 26.

Abstract

The aim of this study was to assess the changes induced by photobiomodulation therapy in oxygenation of normal skin and underlying tissue using hyperspectral imaging combined with a chemometric regression approach. Eleven healthy adult volunteers were enrolled in this study. The dorsal side of the left hand of each subject was exposed to photobiomodulation therapy, while the correspondent side of the right hand was used as a control (placebo effect). Laser irradiation was performed with a laser diode system (635 nm, 15mW, 9 J/cm2) for 900 s. Changes in skin oxygenation were assessed before and after applying the photobiomodulation therapy and placebo using the hyperspectral imaging. Hyperspectral data analysis showed that variations of oxyhemoglobin and deoxyhemoglobin concentrations had no statistical significance in both groups. In conclusion, photobiomodulation therapy does not induce changes in oxyhemoglobin and deoxyhemoglobin concentrations in the normal skin measured from hyperspectral images, at least at λ = 635 nm and 900-s exposure time.

Keywords: Deoxyhemoglobin; Hyperspectral imaging; Low-level laser therapy; Normal skin; Oxyhemoglobin; Tissue oxygenation.

MeSH terms

  • Adult
  • Humans
  • Hyperspectral Imaging
  • Lasers, Semiconductor
  • Low-Level Light Therapy* / methods
  • Oxyhemoglobins
  • Skin / diagnostic imaging
  • Skin / radiation effects

Substances

  • Oxyhemoglobins